Spot on Unbelievable.
I’ll summarise the current estimated timetable (source: Emergence presentation Feb 20, April Newsletter, and clinical trials link helpfully provided by DTshares post (above) and other info on IMU investor website
End Q2 (2nd calendar quarter) 2020, probably mid to late June:
IND Clearance (ie. US FDA clearance of investigational new drug) for PD1 Vaxx phase 1
IND Clearance CHECK Vacc TNBC (Triple Negative Breast Cancer)
IND Clearance VAXinia MAST Study phase 1 (Mixed Advanced Solid Tumours)
Early Q3 2020, perhaps late July
FPI (First Patient In) PD1 Vaxx phase 1 - ie, underway
FPI CHECK Vacc
Mid Q3 2020 perhaps August 2020
FPI VAXinia
End Q3 perhaps late September 2020
HERR Vaxx Phase 2 enrolment completed
End Q4 2020, ie, December 2020
HERR Vaxx Phase 2 PFS Readout (Progression Free Survival) ie final data collection date for primary outcome
End Q2 2021
PD1 Vaxx Phase 1 OBD (Optimal Biological Dose) [remember with HERR Vaxx there were 3 different dosing levels used to arrive at the the OBD which is used in phase 2]
This trial will then be expanded which involves additional patients. They are enrolled after the OBD is identified, and other studies have shown that this process has identified a “higher likelihood of success in Phase 2 trials”.
Early Q2 2021 (according to Clinical Trial info as cited by DTshares updated yesterday 6.5.20) or Mid Q3 2021 on Emergence estimated timeline - obviously Q2 2021 is more recent information
HERR Vaxx OS Readout (Overall Survival) which is the estimated study completion date)
Mid Q4 2021
CHECK Vacc OBD
Early Q1 2022
VAXinia OBD
Late Q1 2022
PD1 Vaxx trial completed
End Q2 2022
VAXinia ICI Combo OBD (Immune Checkpoint Inhibitors in combination with Optimal Biological Dose)
CAUTION: These are estimates on current information provided by IMU available online.
I’m very optimistic about IMU and I will genuinely be surprised if something massively positive doesn’t occur well before the end of the above timeline. By that, I mean success of one or more of the products either as a cure, or cure for certain cancers, or positive results that improve quality of life, or positive results of an IMU produce being used in conjunction with some other product that improve quality of life by extension or remission. If any of those outcomes occur it will be a giant step for humanity, and a bit more than spare change in my pocket. That’s only my opinion. You are entitled to yours.
- Forums
- ASX - By Stock
- IMU
- Ann: Imugene HER-Vaxx Phase 2 Clinical Update
Ann: Imugene HER-Vaxx Phase 2 Clinical Update, page-33
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.7¢ |
Change
0.003(6.82%) |
Mkt cap ! $349.6M |
Open | High | Low | Value | Volume |
4.7¢ | 4.9¢ | 4.5¢ | $963.9K | 20.44M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
24 | 1558493 | 4.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.7¢ | 1495843 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
24 | 1558493 | 0.046 |
28 | 3882668 | 0.045 |
22 | 3052545 | 0.044 |
30 | 3311732 | 0.043 |
27 | 2305818 | 0.042 |
Price($) | Vol. | No. |
---|---|---|
0.047 | 1295843 | 6 |
0.048 | 2511005 | 13 |
0.049 | 1960314 | 10 |
0.050 | 7748220 | 21 |
0.051 | 1883189 | 11 |
Last trade - 16.10pm 05/11/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |